Pay as little as $25, subject to a maximum savings of $100/month
Cardiovascular benefit: In adults with type 2 diabetes who have established cardiovascular risk, a GLP-1 RA may provide cardiovascular benefit, independent of baseline A1C
TNF: tumor necrosis factor
Is the pricing honest and transparent
Our microdosing GLP-1 approach starts with very low, individualized doses that are gradually adjusted based on your bodys feedback and goals not a fixed chart
Tirzepatide Side Effects# Well-characterized from Phase 3 (SURPASS, SURMOUNT) trials and post-market surveillance: Gastrointestinal : Nausea (12-33%), diarrhea (12-21%), vomiting (5-12%), constipation (6-11%) Decreased appetite : Common and expected pharmacological effect Injection site reactions : Mild, occurring in 2-5% of patients Pancreatitis : Rare